Weight-Loss drugs under the microscope: do they really change what you eat?
NCT ID NCT07270497
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how popular weight-loss medications (GLP-1 and GIP/GLP-1 analogs) affect what people eat, their metabolism, and behavior over a year. Researchers will track 100 adults with overweight or obesity to see changes in weight, body composition, and diet quality. The goal is to understand both the benefits and risks, like muscle loss or side effects, to help patients and doctors make better treatment decisions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLP-1 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Klinika Diabetologii i Chorób Wewnętrznych Uniwersyteckiego Centrum Klinicznego Warszawskiego Uniwersytetu Medycznego
RECRUITINGWarsaw, Warszawa, 02-097, Poland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new stomach and gut bypass surgery tackle obesity and diabetes?
- Can a Two-Drug combo tip the scales against obesity?
- Can Weight-Loss surgery change how medications work?
- Coffee grounds probiotic could reshape gut health and fight inflammation
- Can shedding pounds reboot the Heart's exercise engine?
- Can stomach surgery alter how painkillers work?